Literature DB >> 29250269

Bonus vs No Bonus Cryoballoon Isolation for Paroxysmal Atrial Fibrillation Ablation.

Aysenur Ekizler1, Dursun Aras1, Serkan Cay1, Ozcan Ozeke1, Firat Ozcan1, Serkan Topaloglu1.   

Abstract

AIMS: To evaluate the benefit of Bonus freeze using second generation cryoballoon after pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation (PAF).
METHODS: A bonus freeze is performed after proven pulmonary vein isolation (PVI) for cryoballoon ablation of paroxysmal atrial fibrillation (PAF) as standard. In the current study, no additional freeze (No Bonus) after PVI was compared with additional freeze (Bonus) after PVI using second generation cryoballoon.
RESULTS: A total of 136 patients (mean age 58 ± 13 years, 76 male) were included. No Bonus and Bonus groups had 56 and 80 patients, respectively. Follow-up electrocardiography and Holter monitoring were performed at 1, 3, 6, 12 months, and biannually thereafter. The PVI rate was similar after the initial ablation (82% in No Bonus group, 80% in Bonus group, p>0.05) and, at the end of the procedure (99% in No Bonus group and 99% in Bonus group, p>0.05). The median procedure and fluoroscopy times in No Bonus group were 67 (60-74) minutes and 13 (10-15) minutes, which were significantly shorter than the median durations, 85 (76-90) minutes and 17 (15-21) minutes in Bonus group, respectively (all p<0.001). Phrenic nerve palsy was observed less frequently in No Bonus group compared to Bonus group (1 patient (2%) vs. 5 patients (6%), respectively) without statistically significant difference. During a median follow-up of 13 (11-15) months, the rates of patients free from AF were 82% in No Bonus group and 84% in Bonus group, respectively (p>0.05).
CONCLUSIONS: The rate of sinus rhythm at 18 months was similar in patients with PAF who received bonus cryoablation vs patients who did not receive bonus cryoablation.

Entities:  

Keywords:  atrial fibrillation; bonus; cryoablation; recurrence

Year:  2017        PMID: 29250269      PMCID: PMC5673385          DOI: 10.4022/jafib.1513

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  16 in total

1.  Improved 1-year clinical success rate of pulmonary vein isolation with the second-generation cryoballoon in patients with paroxysmal atrial fibrillation.

Authors:  Alexander Fürnkranz; Stefano Bordignon; Daniela Dugo; Laura Perotta; Melanie Gunawardene; Britta Schulte-Hahn; Bernd Nowak; Boris Schmidt; Julian K R Chun
Journal:  J Cardiovasc Electrophysiol       Date:  2014-05-02

2.  Incidence and characteristics of phrenic nerve palsy following pulmonary vein isolation with the second-generation as compared with the first-generation cryoballoon in 360 consecutive patients.

Authors:  Alexander Fürnkranz; Stefano Bordignon; Boris Schmidt; Laura Perrotta; Daniela Dugo; Manuel De Lazzari; Britta Schulte-Hahn; Bernd Nowak; Julian K R Chun
Journal:  Europace       Date:  2015-01-06       Impact factor: 5.214

3.  Comparison of the first and second cryoballoon: high-volume single-center safety and efficacy analysis.

Authors:  Florian Straube; Uwe Dorwarth; Martin Schmidt; Michael Wankerl; Ulrich Ebersberger; Ellen Hoffmann
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-03-07

4.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

5.  Safety and efficacy of a second-generation cryoballoon in the ablation of paroxysmal atrial fibrillation.

Authors:  Raphaël P Martins; David Hamon; Olivier Césari; Albin Behaghel; Nathalie Behar; Jean-Marc Sellal; Jean-Claude Daubert; Philippe Mabo; Dominique Pavin
Journal:  Heart Rhythm       Date:  2014-01-01       Impact factor: 6.343

6.  One-year clinical success of a 'no-bonus' freeze protocol using the second-generation 28 mm cryoballoon for pulmonary vein isolation.

Authors:  Erik Wissner; Christian-Hendrik Heeger; Hanno Grahn; Bruno Reissmann; Peter Wohlmuth; Christine Lemes; Peter Rausch; Shibu Mathew; Andreas Rillig; Sebastian Deiss; Tillman Maurer; Tina Lin; Roland Richard Tilz; Feifan Ouyang; Karl-Heinz Kuck; Andreas Metzner
Journal:  Europace       Date:  2015-04-12       Impact factor: 5.214

7.  Two versus one repeat freeze-thaw cycle(s) after cryoballoon pulmonary vein isolation: the alster extra pilot study.

Authors:  Kyoung Ryul Julian Chun; Alexander Fürnkranz; Ilka Köster; Andreas Metzner; Tobias Tönnis; Peter Wohlmuth; Erik Wissner; Boris Schmidt; Feifan Ouyang; Karl Heinz Kuck
Journal:  J Cardiovasc Electrophysiol       Date:  2012-04-04

8.  Incidence of and risk factors for atrial fibrillation in older adults.

Authors:  B M Psaty; T A Manolio; L H Kuller; R A Kronmal; M Cushman; L P Fried; R White; C D Furberg; P M Rautaharju
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

9.  Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon.

Authors:  Alexander Fürnkranz; Stefano Bordignon; Boris Schmidt; Melanie Gunawardene; Britta Schulte-Hahn; Verena Urban; Frank Bode; Bernd Nowak; Julian K R Chun
Journal:  J Cardiovasc Electrophysiol       Date:  2013-02-11

10.  Second-generation cryoballoon ablation for paroxysmal atrial fibrillation: 1-year follow-up.

Authors:  Gian-Battista Chierchia; Giacomo Di Giovanni; Giuseppe Ciconte; Carlo de Asmundis; Giulio Conte; Juan Sieira-Moret; Moises Rodriguez-Mañero; Ruben Casado; Giannis Baltogiannis; Mehdi Namdar; Yukio Saitoh; Gaetano Paparella; Giacomo Mugnai; Pedro Brugada
Journal:  Europace       Date:  2014-01-28       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.